全文获取类型
收费全文 | 924篇 |
免费 | 97篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 60篇 |
妇产科学 | 8篇 |
基础医学 | 134篇 |
口腔科学 | 42篇 |
临床医学 | 82篇 |
内科学 | 142篇 |
皮肤病学 | 35篇 |
神经病学 | 26篇 |
特种医学 | 220篇 |
外科学 | 48篇 |
综合类 | 38篇 |
预防医学 | 52篇 |
眼科学 | 10篇 |
药学 | 93篇 |
肿瘤学 | 52篇 |
出版年
2019年 | 6篇 |
2018年 | 9篇 |
2017年 | 11篇 |
2016年 | 10篇 |
2015年 | 14篇 |
2014年 | 18篇 |
2013年 | 12篇 |
2012年 | 14篇 |
2011年 | 18篇 |
2010年 | 26篇 |
2009年 | 23篇 |
2008年 | 29篇 |
2007年 | 27篇 |
2006年 | 22篇 |
2005年 | 12篇 |
2004年 | 14篇 |
2003年 | 12篇 |
2002年 | 9篇 |
2001年 | 13篇 |
2000年 | 15篇 |
1999年 | 16篇 |
1998年 | 43篇 |
1997年 | 46篇 |
1996年 | 41篇 |
1995年 | 36篇 |
1994年 | 25篇 |
1993年 | 35篇 |
1992年 | 24篇 |
1991年 | 21篇 |
1990年 | 17篇 |
1989年 | 31篇 |
1988年 | 35篇 |
1987年 | 52篇 |
1986年 | 30篇 |
1985年 | 24篇 |
1984年 | 14篇 |
1983年 | 18篇 |
1982年 | 17篇 |
1981年 | 21篇 |
1980年 | 19篇 |
1979年 | 9篇 |
1978年 | 10篇 |
1977年 | 12篇 |
1976年 | 24篇 |
1975年 | 16篇 |
1974年 | 8篇 |
1968年 | 8篇 |
1934年 | 4篇 |
1927年 | 4篇 |
1926年 | 4篇 |
排序方式: 共有1043条查询结果,搜索用时 78 毫秒
51.
Jessica R Tolman Edwin D Lephart Kenneth DR Setchell Dennis L Eggett Merrill J Christensen 《Nutrition & metabolism》2008,5(1):1-10
Drug-drug interactions have become an important issue in health care. It is now realized that many drug-drug interactions can be explained by alterations in the metabolic enzymes that are present in the liver and other extra-hepatic tissues. Many of the major pharmacokinetic interactions between drugs are due to hepatic cytochrome P450 (P450 or CYP) enzymes being affected by previous administration of other drugs. After coadministration, some drugs act as potent enzyme inducers, whereas others are inhibitors. However, reports of enzyme inhibition are very much more common. Understanding these mechanisms of enzyme inhibition or induction is extremely important in order to give appropriate multiple-drug therapies. In future, it may help to identify individuals at greatest risk of drug interactions and adverse events. 相似文献
52.
Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY- 14,643 总被引:7,自引:6,他引:7
Bojes HK; Germolec DR; Simeonova P; Bruccoleri A; Schoonhoven R; Luster MI; Thurman RG 《Carcinogenesis》1997,18(4):669-674
Several structurally dissimilar hypolipidemic drugs, plasticizers and
halogenated hydrocarbons induce peroxisomes in hepatocytes, and cause
hepatocellular adenoma and carcinoma in rats and mice. The mechanism by
which these agents act is unknown, although recent studies have suggested a
link between increased cell proliferation and hepatic cancer caused by
peroxisome proliferators. Here, we demonstrate that neutralizing antibodies
to tumor necrosis factor alpha (TNF alpha) block increases in protein
kinase C and cell proliferation due to [4-
chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (WY-14,643), a
hypolipidemic drug and potent peroxisome proliferator that causes tumors.
WY-14,643 moderately elevated the level of TNF alpha mRNA in the liver. TNF
alpha was detected immunohistochemically exclusively in Kupffer cells.
These results demonstrate that WY-14,643 acts as an indirect mitogen on
hepatocytes via TNF alpha. We propose that the Kupffer cell, a major source
of TNF alpha in the liver, is involved in the mechanism of the mitogenic
effect of WY-14,643.
相似文献
53.
DR Heller 《Archives of disease in childhood》1994,70(4):339-41; discussion 41-2
54.
55.
56.
The results of Kr-81m/Tc-99m ventilation-perfusion (VP) lung scintigraphy were correlated with the results of pulmonary angiography for 74 patients suspected of having pulmonary embolism (PE). Among patients having a diagnostic scan, the sensitivity and specificity of scintigraphy were 91% and 94%, respectively. Also, 157 consecutive cases of Kr-81m/Tc-99m VP lung scintigraphy were reviewed, and the frequency of an indeterminate scan was found to be 22%. A similar frequency was found for VP scintigraphy with xenon-133. Of eight patients who had indeterminate scans due to the presence of a single VP mismatch, four were demonstrated to have PE by angiography. Kr-81m is an excellent agent for VP scanning in cases of suspected PE, offering accuracy in diagnosis as well as favorable physical properties. 相似文献
57.
58.
Grönefeld GC Israel CW Padmanabhan V Koehler J Cuijpers A Hohnloser SH;WorldWide Gem DR Study Group 《Pacing and clinical electrophysiology : PACE》2002,25(12):1708-1714
Reviews of stored electrograms from ICDs revealed a 5-30% incidence of short-long-short intervals preceding the onset of recurrent ventricular tachyarrhythmias. Rate stabilization by dedicated antibradycardia pacing algorithms has, therefore, been suggested to prevent onset of pause dependent tachyarrhythmias. However, the clinical efficacy of this approach has not been studied systematically. In a prospective multicenter crossover study, patients were randomized to activation or deactivation of an implemented ventricular rate stabilization algorithm (VRS) after first implant of a dual chamber ICD. After 3 months, all patients were crossed over to the alternate programming. The rate of appropriate spontaneous VA episodes was compared between VRS On and VRS Off. Stored electrograms were reviewed for evaluation of the mode of onset of tachyarrhythmias. Overall efficacy analysis was based on 309 patients enrolled in the study. Forty percent (124/309) of the patients experienced 4,973 VA episodes. Based on an intention-to-treat analysis, VRS Off and On arrhythmia incidence was 10.2 and 6.6 normalized to 3 months, respectively (risk reduction 35%; P = 0.18) On an on-treatment basis, a reduction from 9.0 episodes to 8.1 episodes (10% risk reduction, P = 0.24) was seen. In an extended Cox model adjusting for confounding variables, the relative risk for recurrent episodes was 0.92 during VRS On compared to Off (95% CI: 0.58-1.48; P = 0.74). During VRS Off, pause dependent onset was documented in only 36 (8%) of 427 visually analyzed episodes. There was no significant reduction in the incidence of recurrent ventricular tachyarrhythmias with VRS On compared to the Off programming in this prospective study. 相似文献
59.
Jill R Stewart Rebecca J Gast Roger S Fujioka Helena M Solo-Gabriele J Scott Meschke Linda A Amaral-Zettler Erika del Castillo Martin F Polz Tracy K Collier Mark S Strom Christopher D Sinigalliano Peter DR Moeller A Fredrick Holland 《Environmental health : a global access science source》2008,7(Z2):S3
Innovative research relating oceans and human health is advancing our understanding of disease-causing organisms in coastal ecosystems. Novel techniques are elucidating the loading, transport and fate of pathogens in coastal ecosystems, and identifying sources of contamination. This research is facilitating improved risk assessments for seafood consumers and those who use the oceans for recreation. A number of challenges still remain and define future directions of research and public policy. Sample processing and molecular detection techniques need to be advanced to allow rapid and specific identification of microbes of public health concern from complex environmental samples. Water quality standards need to be updated to more accurately reflect health risks and to provide managers with improved tools for decision-making. Greater discrimination of virulent versus harmless microbes is needed to identify environmental reservoirs of pathogens and factors leading to human infections. Investigations must include examination of microbial community dynamics that may be important from a human health perspective. Further research is needed to evaluate the ecology of non-enteric water-transmitted diseases. Sentinels should also be established and monitored, providing early warning of dangers to ecosystem health. Taken together, this effort will provide more reliable information about public health risks associated with beaches and seafood consumption, and how human activities can affect their exposure to disease-causing organisms from the oceans. 相似文献
60.